Workflow
募集资金监管
icon
Search documents
力诺药包:签订募集资金三方监管协议
Xin Lang Cai Jing· 2025-09-11 08:14
Core Viewpoint - The company, Shandong Linuo Special Glass Co., Ltd., has signed a tripartite supervision agreement for fundraising with Minsheng Securities Co., Ltd. and CITIC Bank Jinan Branch, indicating a strategic move to secure funding through convertible bonds [1] Fundraising Details - The company plans to issue 5 million convertible bonds with a face value of 100 RMB each, totaling 500 million RMB in fundraising [1] - After deducting issuance costs, the net amount raised will be 491 million RMB [1] - A new fundraising special account has been opened at CITIC Bank Jinan Branch, and a new tripartite supervision agreement has been signed with the bank and the sponsor [1]
四川科伦药业股份有限公司关于签订募集资金监管协议的公告
Fundraising Overview - The company has issued 30 million convertible bonds at a price of 100 RMB each, raising a total of 300 million RMB, with a net amount of 298,005.40 million RMB after deducting fees [1] - The funds have been verified by KPMG, ensuring the accuracy of the fundraising process [1] Changes in Fund Usage - The company has terminated the original investment projects and adjusted the use of raised funds to focus on new projects related to the construction of intelligent infusion production lines and facility upgrades [2] - The investment allocation has been expanded, with the addition of five new sub-projects [2] Temporary Fund Usage - The company plans to use up to 1.25 billion RMB of idle funds to temporarily supplement working capital, with a repayment period not exceeding 12 months [3] Fund Management and Supervision - The company has established special accounts for the management of raised funds and signed regulatory agreements with banks and its sponsor to ensure proper fund usage [4][5] - The agreements stipulate that the sponsor will supervise the fund usage and conduct semi-annual checks [6] - The banks are required to provide monthly account statements and notify the sponsor of any significant withdrawals [7] Agreement Validity - The agreements will remain effective until all funds are fully utilized and the accounts are closed [8]
金沃股份: 关于签订募集资金三方监管协议的公告
Zheng Quan Zhi Xing· 2025-08-29 16:17
Fundraising Overview - Zhejiang Jinwo Precision Engineering Co., Ltd. issued 3,100,000 convertible bonds with a face value of RMB 100 each, raising a total of RMB 310 million, with a net amount of RMB 302,849,245.29 after deducting issuance costs of RMB 7,150,754.71 [1][2] - The funds were deposited into a designated account on October 20, 2022, and the situation was verified by Tianheng Accounting Firm [1] Use of Funds - On August 15, 2025, the company’s board approved the temporary use of up to RMB 30 million of idle funds to supplement working capital, with a repayment period not exceeding 12 months [1][2] - As of August 20, 2025, the balance in the special account for temporarily supplementing working capital was RMB 0.00 [2] Regulatory Compliance - The company established a special account for the temporary use of idle funds and signed a tripartite supervision agreement with China Merchants Bank and the sponsor, GF Securities [2][3] - The agreement stipulates that idle funds can only be used for temporary working capital and must comply with relevant regulations and the company's fundraising management system [2][3] - The supervising party has the right to conduct on-site investigations and inquiries regarding the use of funds, ensuring strict adherence to management protocols [2][3]
协昌科技: 国金证券股份有限公司关于江苏协昌电子科技集团股份有限公司2025年半年度持续督导跟踪报告
Zheng Quan Zhi Xing· 2025-08-26 13:23
Group 1 - The company has experienced a continuous decline in operating income and net profit since the market began, with a projected net profit of 37.05 million yuan for 2024, representing a 55.57% decrease compared to the same period last year [1][2][3] - For the first half of 2025, the company's operating income was 155.86 million yuan, down 18.51% year-on-year, while the net profit attributable to shareholders was 7.10 million yuan, a decline of 73.26% [2][3] - The net profit after deducting non-recurring gains and losses for the first half of 2025 was -5.89 million yuan, reflecting a significant drop of 129.39% [2][3] Group 2 - The company has invested a total of 81.95 million yuan in fundraising projects as of the end of June 2025, with an investment progress of 19.54%, indicating a delay compared to the investment plan [1][2] - The construction and decoration of the fundraising projects are still in progress, with the expected completion date set for December 31, 2026 [1][2] - The company is actively assessing market conditions and its own capabilities to prudently advance the implementation of fundraising projects while fulfilling relevant decision-making procedures and information disclosure obligations [1][2][3]
大名城: 上海大名城企业股份有限公司募集资金管理制度
Zheng Quan Zhi Xing· 2025-08-22 13:12
Core Viewpoint - The document outlines the fundraising management system of Shanghai Daming City Enterprise Co., Ltd., emphasizing the importance of proper management and utilization of raised funds to protect investors' rights, particularly those of small and medium investors [1]. Group 1: Fundraising Management Principles - The company must use raised funds specifically for their intended purposes, aligning with national industrial policies and legal regulations, and should primarily benefit the main business to enhance competitiveness and innovation [2]. - A robust internal control system must be established for the management, use, and supervision of raised funds, including clear approval authority and risk control measures [2][3]. - The company’s controlling shareholders and actual controllers are prohibited from misappropriating or occupying the raised funds, and any such incidents must be disclosed promptly [2][3]. Group 2: Fund Storage and Management - Raised funds must be stored in a dedicated account approved by the board, and no other accounts should be used for these funds [3][4]. - The financial department is responsible for establishing and managing the dedicated account, ensuring that all funds are deposited promptly [3][4]. - Regular audits of the fund's storage and usage must be conducted, with findings reported to the audit committee [4][5]. Group 3: Fund Usage Regulations - The company must adhere to the usage plan outlined in the fundraising application documents and cannot change the purpose without proper procedures [5][6]. - If a fundraising project faces significant changes in market conditions or delays, the feasibility and expected returns must be reassessed [6][7]. - Funds cannot be used for financial investments or to benefit related parties improperly [7][8]. Group 4: Changes in Fund Usage - Any changes in the use of raised funds must be approved by the board and disclosed to shareholders [25][26]. - The company must ensure that new investment projects are viable and have good market prospects [26][27]. - If funds are to be transferred or replaced, detailed reasons and financial implications must be disclosed [29][30]. Group 5: Oversight and Reporting - The company must provide accurate and complete disclosures regarding the actual use of raised funds, especially if there are significant deviations from the planned usage [30][31]. - The board must conduct semi-annual reviews of fundraising projects and report on the status of fund usage [31][32]. - Independent auditors and financial advisors are required to conduct ongoing supervision and provide reports on the management and usage of raised funds [32][33].
紫光国微: 渤海证券股份有限公司关于紫光国芯微电子股份有限公司的专项现场检查报告
Zheng Quan Zhi Xing· 2025-08-21 05:39
Core Viewpoint - The report details a special on-site inspection conducted by Bohai Securities on Unisoc Microelectronics Co., Ltd. regarding the improper use of raised funds for project expenditures without following necessary review procedures and disclosure obligations [1][2]. Group 1: Inspection Overview - Bohai Securities, as the sponsor for Unisoc's convertible bond issuance, conducted the inspection following a warning letter from the Hebei Securities Regulatory Bureau due to the company's failure to adhere to regulatory requirements [1][2]. - The company had initially planned to invest a total of 10.5 billion yuan in various projects but later revised this amount to 7.5 billion yuan, reallocating funds to specific projects [1]. Group 2: Fund Usage and Violations - The company utilized raised funds to reimburse its own expenditures on project costs, including equipment and materials, without proper review and disclosure [2][3]. - The company received a warning letter from the Hebei Securities Regulatory Bureau on July 30, 2025, for these violations, which were recorded in the securities market integrity archive [2]. Group 3: Inspection Findings and Remedial Actions - The inspection revealed that the company did not follow the required review procedures and disclosure obligations for the use of raised funds [3]. - In response, the company has committed to improving the accuracy of its information disclosures and has taken steps to ensure compliance with relevant regulations [3][4]. Group 4: Future Plans - Bohai Securities plans to enhance its oversight of the company's use of raised funds and ensure adherence to regulatory requirements moving forward [4].
浩欧博: 江苏浩欧博生物医药股份有限公司第三届监事会第十九次会议决议公告
Zheng Quan Zhi Xing· 2025-08-14 16:39
Meeting Details - The 19th meeting of the third Supervisory Board of Jiangsu Haoaobo Biopharmaceutical Co., Ltd. was held on August 13, 2025, with all three supervisors present [1] - The meeting was convened in accordance with the Company Law of the People's Republic of China and the company's articles of association, ensuring the legality and validity of the resolutions [1] Financial Report Review - The Supervisory Board reviewed the company's 2025 semi-annual report, confirming that its preparation and review procedures comply with relevant laws and internal management regulations [1] - The report accurately reflects the company's financial status and operating results for the first half of 2025, with all members of the Supervisory Board ensuring the information disclosed is true, accurate, and complete [1] Fund Management - The Supervisory Board assessed the management of raised funds, confirming compliance with the regulations governing the management of raised funds and the company's fundraising management system [2] - The company has stored and utilized the raised funds in a dedicated account, with no violations or damages to the interests of the company and its shareholders [2] Auditor Appointment - The Supervisory Board approved the appointment of Ernst & Young Hua Ming LLP as the auditing firm for the company's 2025 financial report and internal control audit, citing their qualifications and experience [3] - The resolution received unanimous approval from all supervisors, with 100% of the voting rights in favor [3]
锦富技术: 关于签订募集资金三方监管协议的公告
Zheng Quan Zhi Xing· 2025-08-14 16:15
Fundraising Overview - The company, Suzhou Jinfeng Technology Co., Ltd., has received approval from the China Securities Regulatory Commission to issue 205,000,000 shares at a price of 3.60 RMB per share, raising a total of 738,000,000 RMB, with a net amount of 724,758,218.85 RMB after deducting issuance costs [1][2][3] Special Account and Supervision Agreement - A special account for the raised funds has been opened at China Minsheng Bank, Suzhou Branch, and a tripartite supervision agreement has been signed with the bank and the sponsor, Guotai Junan Securities [2][3] - The special account is designated for the storage and use of funds for working capital and cannot be used for other purposes [3][4] - The sponsor is responsible for supervising the use of the raised funds and can conduct on-site investigations and written inquiries [3][4] Key Provisions of the Agreement - The agreement stipulates that the bank must provide monthly account statements to the company and the sponsor [4][5] - Any withdrawal exceeding 1 million RMB must be reported to the sponsor along with a detailed expenditure list [4][5] - The agreement is governed by the laws of the People's Republic of China and can be terminated under specific conditions [5]
多浦乐:关于签订募集资金三方监管协议的公告
Zheng Quan Ri Bao· 2025-08-14 13:09
Core Viewpoint - Duople's announcement on August 14 indicates the establishment of a special fundraising account for the "Non-destructive Testing Intelligent Production Base Construction Project" [2] Group 1 - The company will hold its 19th meeting of the second board on July 15, 2025, to review the proposal for setting up a special fundraising account [2] - The special account will be established at CITIC Bank's Guangzhou Kejiao City branch for the storage, use, and management of funds [2] - The chairman or designated personnel will be authorized to handle the opening of the special fundraising account and the signing of the tripartite supervision agreement [2]
每周股票复盘:工业富联(601138)签署募集资金监管协议及股份回购进展
Sou Hu Cai Jing· 2025-08-09 17:20
Core Viewpoint - Industrial Fulian (601138) has seen a significant increase in stock price, closing at 36.59 yuan, up 10.88% from the previous week, with a market capitalization of 726.658 billion yuan, ranking 1st in the consumer electronics sector and 15th in the A-share market [1] Company Announcements Summary - Industrial Fulian announced the signing of a tripartite supervision agreement for the storage of raised funds, with a total of 1,969,530,023 shares issued at a price of 13.77 yuan per share, raising approximately 27.12 billion yuan, with a net amount of about 26.72 billion yuan after deducting issuance costs [1] - As of December 31, 2024, the total amount of raised funds used is approximately 25.28 billion yuan, leaving a balance of about 3.91 billion yuan [1] - The company has approved the establishment of a new R&D center for precision components for next-generation smartphones and signed the tripartite supervision agreement on August 4, 2025 [1] Share Buyback Progress Summary - The share buyback plan was first disclosed on April 15, 2025, with a buyback period from April 30, 2025, to April 29, 2026, and an expected buyback amount between 50 million and 100 million yuan [2] - As of July 31, 2025, the company has repurchased 7.6974 million shares, accounting for 0.04% of the total share capital, with a total expenditure of approximately 14.71 million yuan [2] - The repurchase price ranged from 18.40 yuan to 19.84 yuan per share, with the maximum repurchase price adjusted to 19.36 yuan due to the 2024 annual equity distribution [2]